This data indicated that IGF-1 affects the stable glucose metabolism and maintenance of weight gain in AD, suggesting that AD patients and AD model mice exhibit a glucose tolerance, impaired insulin sensitivity [63], and a poor systemic metabolism [64,65]. The gene discussed is IGF1; the disease is glucose measurement.